ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $225,000 | +43.3% | 62,433 | 0.0% | 0.03% | +30.0% |
| Q4 2020 | $157,000 | 0.0% | 62,433 | 0.0% | 0.02% | -9.1% |
| Q3 2020 | $157,000 | -23.4% | 62,433 | 0.0% | 0.02% | -24.1% |
| Q2 2020 | $205,000 | +34.0% | 62,433 | 0.0% | 0.03% | +26.1% |
| Q1 2020 | $153,000 | -48.1% | 62,433 | 0.0% | 0.02% | -36.1% |
| Q4 2019 | $295,000 | +10.5% | 62,433 | 0.0% | 0.04% | 0.0% |
| Q3 2019 | $267,000 | -30.8% | 62,433 | 0.0% | 0.04% | -30.8% |
| Q2 2019 | $386,000 | +60.8% | 62,433 | 0.0% | 0.05% | +48.6% |
| Q1 2019 | $240,000 | +105.1% | 62,433 | 0.0% | 0.04% | +84.2% |
| Q4 2018 | $117,000 | -20.9% | 62,433 | 0.0% | 0.02% | -17.4% |
| Q3 2018 | $148,000 | -21.7% | 62,433 | 0.0% | 0.02% | -25.8% |
| Q2 2018 | $189,000 | -24.1% | 62,433 | -1.6% | 0.03% | -26.2% |
| Q1 2018 | $249,000 | -3.5% | 63,433 | +1.6% | 0.04% | -2.3% |
| Q4 2017 | $258,000 | -32.6% | 62,433 | 0.0% | 0.04% | -42.7% |
| Q3 2017 | $383,000 | -1.3% | 62,433 | 0.0% | 0.08% | -6.2% |
| Q2 2017 | $388,000 | -2.0% | 62,433 | 0.0% | 0.08% | 0.0% |
| Q1 2017 | $396,000 | +18.6% | 62,433 | 0.0% | 0.08% | +12.7% |
| Q4 2016 | $334,000 | -4.8% | 62,433 | 0.0% | 0.07% | -7.8% |
| Q3 2016 | $351,000 | +2.3% | 62,433 | 0.0% | 0.08% | 0.0% |
| Q2 2016 | $343,000 | -25.9% | 62,433 | 0.0% | 0.08% | -24.5% |
| Q1 2016 | $463,000 | -10.8% | 62,433 | 0.0% | 0.10% | -13.6% |
| Q4 2015 | $519,000 | -7.8% | 62,433 | 0.0% | 0.12% | -13.2% |
| Q3 2015 | $563,000 | -24.8% | 62,433 | 0.0% | 0.14% | -19.0% |
| Q2 2015 | $749,000 | -44.3% | 62,433 | -50.0% | 0.17% | +54.1% |
| Q1 2015 | $1,345,000 | +165.8% | 124,866 | +25.1% | 0.11% | -3.5% |
| Q4 2014 | $506,000 | +91.7% | 99,850 | 0.0% | 0.11% | +36.1% |
| Q3 2014 | $264,000 | -34.3% | 99,850 | 0.0% | 0.08% | -39.9% |
| Q2 2014 | $402,000 | -12.0% | 99,850 | 0.0% | 0.14% | -10.4% |
| Q1 2014 | $457,000 | +5.5% | 99,850 | 0.0% | 0.15% | +3.4% |
| Q4 2013 | $433,000 | +10.2% | 99,850 | 0.0% | 0.15% | -5.7% |
| Q3 2013 | $393,000 | +86.3% | 99,850 | 0.0% | 0.16% | +88.1% |
| Q2 2013 | $211,000 | – | 99,850 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |